Bayer Wins Bid to Block Norbrook Sale of Generic Baytril

Bayer AG won an agreement from the U.S. Food and Drug Administration to block sales of a generic version of its livestock antibiotic Baytril 100 made by Norbrook Laboratories Ltd.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.